Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
Tag: IPO
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of ...
Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases
Cell therapy first reached patients as treatments for cancer. Artiva Biotherapeutics is part of a growing group of companies working ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!